Recent Quarter Total Invested
$1.31 M
Recent Quarter Institutional Ownership Percentage
8.41%
Total Invested of Last Quarter
$2.43 M
Ownership Percentage of Last Quarter
8.26%
Sensei Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 08/14/2024 | 650,000 | $403,065 | 100.00% | 2.59% |
| VANGUARD GROUP INC | 08/13/2024 | 618,757 | $383,691 | 7.83% | 2.47% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 223,785 | $138,769 | 6.06% | 0.89% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2024 | 172,835 | $107,175 | 100.00% | 0.69% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 163,139 | $101,180 | 19.68% | 0.65% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 77,900 | $48,306 | -31.00% | 0.31% |
| NORTHERN TRUST CORP | 08/14/2024 | 25,983 | $16,112 | -0.25% | 0.10% |
| STATE STREET CORP | 08/14/2024 | 25,774 | $15,982 | 0.00% | 0.10% |
| CRESSET ASSET MANAGEMENT, LLC | 08/14/2024 | 19,671 | $12,198 | 0.00% | 0.08% |
| TWO SIGMA SECURITIES, LLC | 08/14/2024 | 18,600 | $11,534 | 100.00% | 0.07% |
| CITADEL ADVISORS LLC | 08/14/2024 | 15,366 | $9,528 | -35.61% | 0.06% |
| LEO WEALTH, LLC | 07/17/2024 | 14,845 | $9,205 | 0.00% | 0.06% |
| XTX TOPCO LTD | 08/12/2024 | 14,047 | $8,711 | 100.00% | 0.06% |
| RAYMOND JAMES & ASSOCIATES | 07/19/2024 | 14,000 | $8,681 | 0.00% | 0.06% |
| MORGAN STANLEY | 08/14/2024 | 12,219 | $7,577 | 0.00% | 0.05% |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 07/30/2024 | 11,000 | $6,821 | 0.00% | 0.04% |
| NATIONAL BANK OF CANADA /FI/ | 08/02/2024 | 10,000 | $5,900 | 100.00% | 0.04% |
| BLACKROCK INC. | 08/13/2024 | 7,777 | $4,823 | -76.84% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 7,087 | $4,394 | 5.57% | 0.03% |
| BANQUE CANTONALE VAUDOISE | 07/31/2024 | 3,900 | $2,000 | 0.00% | 0.02% |
| JPMORGAN CHASE & CO | 08/12/2024 | 748 | $464 | 11.98% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 139 | $86 | -99.85% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 4 | $2 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| NEWTYN MANAGEMENT, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Sensei Biotherapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of SNSE shares?
During the previous two years, 31 institutional investors and hedge funds held shares of Sensei Biotherapeutics, Inc.. The most heavily invested institutionals were:
Ikarian Capital, LLC: 650,000
VANGUARD GROUP INC: 618,757
RENAISSANCE TECHNOLOGIES LLC: 223,785
BOOTHBAY FUND MANAGEMENT, LLC: 172,835
GEODE CAPITAL MANAGEMENT, LLC: 163,139
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 77,900
-
What percentage of Sensei Biotherapeutics, Inc. stock is owned by institutional investors?
8.41% of Sensei Biotherapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at SNSE ?
Institutional investors have bought a total of 2.12 M shares in the last 24 months. This purchase volume represents approximately $1.08 M in transactions.